What Is Amphastar Pharmaceuticals, Inc. (AMPH) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Amphastar Pharmaceuticals, Inc.. Trading at $19.29 against an estimated intrinsic value of $43.15, 10 of 12 active models flag meaningful upside of +123.7% on average. The most optimistic model, RCMH-DCF, places fair value at $78.84 (+308.7%), while Dynamic NAV — the most conservative — estimates $3.33 (-82.7%). This +391.4% gap reflects genuine analytical uncertainty about Amphastar Pharmaceuticals, Inc.'s intrinsic worth.
What Do the Models Say About AMPH?
12 of 13 models are currently active for AMPH. Of these, 10 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates AMPH's intrinsic value at $65.60, implying +240.1% upside from the current price. See which stocks rank higher →
How Does AMPH Rank in Drug Manufacturers - Specialty & Generic?
Among 13 Drug Manufacturers - Specialty & Generic stocks, AMPH ranks #1 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places AMPH in the top tier.
Amphastar Pharmaceuticals, Inc.'s positioning within the Drug Manufacturers - Specialty & Generic segment means that pipeline depth and stage distribution plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.
Is AMPH a Value Trap?
The Value Trap algorithm is not active for AMPH. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Amphastar Pharmaceuticals, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Amphastar Pharmaceuticals, Inc. earns a quality score of 10.0/10. This exceptional rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +391.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AMPH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AMPH's 12 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad